4-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]aniline structure
|
Common Name | 4-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]aniline | ||
---|---|---|---|---|
CAS Number | 1246203-34-8 | Molecular Weight | 453.445 | |
Density | 1.5±0.1 g/cm3 | Boiling Point | 705.5±70.0 °C at 760 mmHg | |
Molecular Formula | C22H21F2N7O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 380.5±35.7 °C |
Name | 4-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]aniline |
---|---|
Synonym | More Synonyms |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 705.5±70.0 °C at 760 mmHg |
Molecular Formula | C22H21F2N7O2 |
Molecular Weight | 453.445 |
Flash Point | 380.5±35.7 °C |
Exact Mass | 453.172485 |
PSA | 104.21000 |
LogP | 2.13 |
Vapour Pressure | 0.0±2.2 mmHg at 25°C |
Index of Refraction | 1.700 |
~86% 4-[4-[2-(difluo... CAS#:1246203-34-8 |
Literature: PATHWAY THERAPEUTICS INC.; REWCASTLE, Gordon, William; GIDDENS, Anna, Claire; GAMAGE, Swarnalatha, Akuratiya Patent: WO2012/44641 A1, 2012 ; Location in patent: Page/Page column 46; 82-84 ; WO 2012/044641 A1 |
~% 4-[4-[2-(difluo... CAS#:1246203-34-8 |
Literature: PATHWAY THERAPEUTICS INC.; REWCASTLE, Gordon, William; GIDDENS, Anna, Claire; GAMAGE, Swarnalatha, Akuratiya Patent: WO2012/44641 A1, 2012 ; WO 2012/044641 A1 |
Precursor 2 | |
---|---|
DownStream 1 | |
Benzenamine, 4-[4-[2-(difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl]- |
4-(4-(2-(difluoromethyl)-4-methoxy-1H-benzo[d]imidazol-1-yl)-6-morpholino-1,3,5-triazin-2-yl)aniline |
4-(4-(2-(difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl)-6-(4-morpholinyl)-1,3,5-triazin-2-yl)aniline |
4-{4-[2-(Difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl}aniline |